Literature DB >> 33682266

Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation.

Hernan R Bello1, Zaid K Mahdi2, Shu K Lui2, Sadhna B Nandwana1, Peter A Harri1, Amir H Davarpanah1.   

Abstract

Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer death in the United States with the incidence rate more than doubling in 20 years. HCC is unique since a noninvasive diagnosis can be achieved with imaging alone when specific clinical criteria and imaging characteristics are met, obviating the need for tissue sampling. However, HCC is a highly heterogeneous neoplasm. Atypical HCC subtypes vary significantly in their morphology, which can be attributed to specific histologic and molecular features, and can cause deviations from the classic imaging characteristics. The different morphologic subtypes of HCC frequently present a diagnostic challenge for radiologists and pathologists since their imaging and pathologic features can overlap with those of non-HCC malignancies. Identifying an atypical subtype can have important clinical implications. Liver transplant, albeit a scarce and limited resource, is the optimal treatment for conventional HCC, potentially curing both the tumor and the underlying pre-malignant condition. Some HCC subtypes as well as mimickers are associated with unacceptably high recurrence and poor outcome after transplant, and there remains limited data on the role and prognosis of liver transplantation for treatment of rare HCC subtypes. Other subtypes tend to recur later than classic HCC, potentially requiring a different follow-up scheme. This review will discuss the appearance of different HCC subtypes in relation to their histopathologic features. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 3.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  Hepatocellular carcinoma; atypical; radiology-pathology correlation; subtypes

Mesh:

Year:  2021        PMID: 33682266     DOI: 10.1002/jmri.27553

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

Review 1.  Imaging mimickers of cholangiocarcinoma: a pictorial review.

Authors:  Si Min Chiow; Hau Wei Khoo; Jee Keem Low; Cher Heng Tan; Hsien Min Low
Journal:  Abdom Radiol (NY)       Date:  2022-01-03

2.  A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm).

Authors:  Sisi Zhang; Lei Huo; Juan Zhang; Yayuan Feng; Yiping Liu; Yuxian Wu; Ningyang Jia; Wanmin Liu
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 3.  Current Imaging Diagnosis of Hepatocellular Carcinoma.

Authors:  Evangelos Chartampilas; Vasileios Rafailidis; Vivian Georgopoulou; Georgios Kalarakis; Adam Hatzidakis; Panos Prassopoulos
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

4.  The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt.

Authors:  Dina Sweed; Enas Sweed; Inas Moaz; Asmaa Mosbeh; Yahya Fayed; Sara Mohamed Abd Elhamed; Eman Sweed; Mahmoud Macshut; Shimaa Abdelsattar; Shimaa Kilany; Sara A Saied; Reda Badr; Mahmoud S Abdallah; Nermine Ehsan
Journal:  World J Surg Oncol       Date:  2022-09-19       Impact factor: 3.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.